Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid + Rituximab vs Steroid + Cyclophosphamide in Acquired Hemophilia A
NCT03384277Phase 4Completed
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Dec 2017
- Primary completion
- Jun 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab in acquired hemophilia A (AHA), sponsored by Institute of Hematology and Blood Diseases Hospital. Started Dec 2017; status: completed.
02
Drugs
rituximab
03
Conditions
acquired hemophilia A (AHA)
Beyond the preview
Go deeper on NCT03384277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03384277.